Teladoc Health, Inc. (TDOC)
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$6.28-2.94%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · TDOC
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -64.9% |
| Our one-year growth estimate | diamond | -3.3% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 61.6 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 21 industry peers · Company calendar date is not available
TDOC — CEO transition
Dated 2026-08-31
CFO — Michael Grasher: The filing announces the external hire of a new CFO to replace an interim officer, which is a significant management change but not a departure of a sitting executive.
Why it matters: Management aims to reduce net loss per share. Staying within the range shows progress.
Supportive ifNet loss per share remains between $0.75 and $1.00 for full year 2026.
Worry ifNet loss per share exceeds $1.00 for full year 2026.
Why it matters: A stable or improving growth rate is crucial for meeting full-year revenue guidance. It indicates demand for services.
Supportive ifThe quarterly revenue growth rate stays the same or gets better than before.
Worry ifThe quarterly revenue growth rate drops a lot compared to earlier quarters.
Why it matters: If healthcare sector growth speeds up, it could benefit Teladoc. This would signal a stronger market environment.
Supportive ifHealthcare sector revenue growth exceeds 12% year over year.
Worry ifHealthcare sector revenue growth stays below 10% year over year.
Why it matters: Confirming revenue guidance is important for investor trust and growth.
Supportive ifManagement confirms full year 2026 revenue guidance of $2,362 - $2,447 million.
Worry ifManagement cuts the 2026 revenue guidance to below $2,362 million.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$224 on $10,000 · ±2.2% | How much price usually moves either way. |
| Bad day | $556 loss on $10,000 · 5.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $5,275 loss on $10,000 · 52.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: BetterHelp revenue fell 12% in Q2. A rise in revenue shows recovery and demand.
Supportive ifBetterHelp segment revenue growth turns positive year over year in Q3 2026.
Worry ifBetterHelp segment revenue continues to decline year over year in Q3 2026.
Why it matters: Management expects Q3 revenue to be between $569 and $609 million. This shows stability.
Supportive ifQ3 revenue reported at or above $609 million.
Worry ifQ3 revenue reported below $569 million.
Why it matters: Management aims to reduce net loss per share to between $0.75 and $1.00 for 2026. A smaller loss is a positive sign.
Supportive ifNet loss per share reported below $0.30 in Q3 2026.
Worry ifNet loss per share reported above $0.30 in Q3 2026.
Why it matters: Integrated Care revenue grew 1% in Q2. Higher growth indicates stronger demand and performance.
Supportive ifIntegrated Care segment revenue growth reported above 2% year over year in Q3 2026.
Worry ifIntegrated Care segment revenue growth reported below 1% year over year in Q3 2026.